Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-24
TEVA PHARMA
Dec-13
AUROBINDO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1773,528-   
Low Rs5173,065-   
Sales per share (Unadj.) Rs495.02,024.7-  
Earnings per share (Unadj.) Rs54.1126.5-  
Cash flow per share (Unadj.) Rs80.1290.1-  
Dividends per share (Unadj.) Rs4.50110.72-  
Avg Dividend yield %0.53.4 15.8%  
Book value per share (Unadj.) Rs509.32,249.0-  
Shares outstanding (eoy) m585.94848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.71.6 105.1%   
Avg P/E ratio x15.726.1 60.1%  
P/CF ratio (eoy) x10.611.4 93.1%  
Price / Book Value ratio x1.71.5 113.5%  
Dividend payout %8.387.5 9.5%   
Avg Mkt Cap Rs m496,2902,795,245 17.8%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m39,2290-   
Avg. sales/employee Rs Th038,200.9-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,386.4-  
INCOME DATA
Net Sales Rs m290,0191,716,939 16.9%  
Other income Rs m5,5740-   
Total revenues Rs m295,5931,716,939 17.2%   
Gross profit Rs m56,340470,185 12.0%  
Depreciation Rs m15,217138,782 11.0%   
Interest Rs m2,89733,723 8.6%   
Profit before tax Rs m43,800297,679 14.7%   
Minority Interest Rs m01,352 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-195,410 -0.0%   
Tax Rs m12,110-3,634 -333.2%   
Profit after tax Rs m31,690107,256 29.5%  
Gross profit margin %19.427.4 70.9%  
Effective tax rate %27.6-1.2 -2,264.6%   
Net profit margin %10.96.2 174.9%  
BALANCE SHEET DATA
Current assets Rs m237,7191,159,614 20.5%   
Current liabilities Rs m121,9911,011,282 12.1%   
Net working cap to sales %39.98.6 461.9%  
Current ratio x1.91.1 169.9%  
Inventory Days Days1791 18.6%  
Debtors Days Days6196 63.2%  
Net fixed assets Rs m196,532560,790 35.0%   
Share capital Rs m5864,226 13.9%   
"Free" reserves Rs m297,8420-   
Net worth Rs m298,4281,907,194 15.6%   
Long term debt Rs m21,349877,909 2.4%   
Total assets Rs m438,5893,923,756 11.2%  
Interest coverage x16.19.8 164.0%   
Debt to equity ratio x0.10.5 15.5%  
Sales to assets ratio x0.70.4 151.1%   
Return on assets %7.93.6 219.5%  
Return on equity %10.65.6 188.8%  
Return on capital %14.64.9 296.1%  
Exports to sales %32.90-   
Imports to sales %11.50-   
Net fx Rs m60,1520-   
CASH FLOW
From Operations Rs m24,345273,591 8.9%  
From Investments Rs m-42,560-96,944 43.9%  
From Financial Activity Rs m8,004-328,191 -2.4%  
Net Cashflow Rs m-10,068-151,544 6.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 84.52 Rs / USD

Compare AUROBINDO PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare AUROBINDO PHARMA With: COLINZ LABOR  AJANTA PHARMA  SUPRIYA LIFESCIENCE   BAJAJ HEALTHCARE  GANGA PHARMACEUTICALS  



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.